Clinical Trial Update: A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 study of SPH3127 for mild to moderate ulcerative colitis has completed. This update confirms the Phase 2 trial status but does not provide results in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SPH3127

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Mild to Moderate Ulcerative Colitis | Phase 2 | Status: COMPLETED